Monday morning was a dull one at Wave Life Sciences (NASDAQ:WVE). This was because the company’s shares declined by 50%. About the flop Analysts attribute this major drop to the recent discontinuation of the company’s suvodirsen. It was a product under development to help patients struggling with a condition known as Duchenne muscular dystrophy. DMD […]
Wave Life Sciences
Recent Posts
Futuris Company Announces Cancellation of Acquisition of LotusUSA Inc.
Ronaldinho and DRYWORLD Extend Partnership to 2033
Galexxy Holdings Inc., Appoints High Profile Chief Marketing Officer
RemSleep Holdings Inc. Provides a Corporate Update and Correction
Winners Partner “Horse Races Now” App updated in the Apple App Store and Google Play Store allowing its Users to “Bet Now” with VegasWinners Sportsbook Affiliate Partners
Popular Post
-
Hollywood Star Cuts Enters Into Acquisition Agreement!
-
FEED EARTH NOW (FEN) ANNOUNCES FOOD WASTE RECYCLING SYSTEM IN CALIFORNIA
-
Kimberly Goldwin Poised to Become Next President of ABC News
-
Spotify Records 20% Increase in Paid Subscribers in the Second Quarter
-
JPMorgan Bringing Back Employees to Work From Office
